Presentation, prognosis and outcome of IgA nephropathy in Indian adults

Nephrology

Volumn 10, Issue 5, 2005, Pages 496-503

  Chacko, Bobby ^a   John, George T ^a   Neelakantan, Nithya ^a   Korula, Anila ^a   Balakrishnan, Narasimhan ^a   Kirubakaran, Meshach G ^a   Jacob, Chakko K ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

IgA nephropathy; Progression; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIET; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INDIAN; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; INDIA; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 28444440904     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00445.x     Document Type: Article

References (25)

1. Berger J. Hinglais: Les depots intercapillaires d'IgA - IgG. J. Urol. Nephrol. 1968; 74: 604.
2. Kincaid-Smith P, Nicholls K. Mesangial IgA nephropathy. Am. J. Kidney Dis. 1983; 3: 90-102.
3. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: A morphological and clinical study. Clin. Nephrol. 1987; 27: 131-40.
4. Muthukumar T, Fernando ME, Jayakumar M. Prognostic factors in immunoglobulin-A nephropathy. J. Assoc. Physicians India 2002; 50: 1354-9.
5. George J, Ninan VT, Thomas PP, Jacob CK, Shastry JC. Primary IgA nephropathy in adults. J. Assoc. Physicians India 1993; 41: 489-91.
6. Sehgal S, Datta BN, Sakhuja V, Chugh KS. Primary IgA nephropathy: a preliminary report. Indian J. Pathol. Microbiol. 1995; 38: 233-7.
7. Bhuyan UN, Dash SC, Srivastava RN, Tiwari SC, Malhotra KK. IgA associated glomerulonephritis. J. Assoc. Physicians India 1992; 40: 310-13.
8. K/DOQI Chronic Disease Practice Guidelines for Chronic Kidney Disease. Evaluation, classification and stratification. Am. J. Kidney Dis. 2002; 39 (Suppl. 1): S1-76.
9. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am. J. Kidney Dis. 1997; 29: 829-42.
10. Emancipator SN. IgA nephropathy and Henoch Sconlein syndrome. In: Jennette JC, Olson JL, eds. Heptinstalls Pathology of the Kidney, 5th edn. Philadelphia: Lippincott Raven Publishers, 1998; 479-539.
11. Ibels LS, Gyory AZ. Primary IgA nephropathy: Natural history and factors of importance in the progression of renal impairment. Kidney Int. 1997; 61 (Suppl.): S67-70.
12. Rauta V, Finne P. Factors associated with progression of IgA nephropathy are related to renal function: A model for estimating risk of progression in mild disease. Clin. Nephrol. 2002; 58: 85-94.
13. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin. Nephrol. 1992; 37: 235-8.
14. Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant. 2000; 15: 34-42.
15. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q. J. Med. 1986; 59: 363-78.
16. Lee SM, Rao VM, Franklin WA et al. IgA nephropathy: Morphologic predictors of progressive renal disease. Hum. Pathol. 1982; 13: 314-22.
17. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q. J. Med. 1984; 53: 227-50.
18. Sakai O, Kitajima T, Kawamura K, Ueda Y. Clinicopathological studies on IgA glomerulonephritis. In: Yoshitoshi Y, Ueda Y (eds). Glomerulonephritis. Baltimore: University Park Press, 1979; 167.
19. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 1991; 18: 12-19.
20. Beukhof JR, Kardaun O. Toward individual prognosis of IgA nephropathy. Kidney Int. 1986; 29: 549-56.
21. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore) 1985; 64: 49-60.
22. Woo KT, Edmondson RPS, Wu AYT et al. The natural history of IgA nephritis in Singapore. Clin. Nephrol. 1986; 25: 15-21.
23. Harden PN, Geddes C, Rowe PA et al. Polymorphisms in angiotensin- converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-42.
24. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobin a nephropathy in Caucasian patients. J. Clin. Invest. 1997; 100: 814-20.
25. Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J. Am. Soc. Nephrol. 1999; 10: 1772-7.